Rebecca Paintin 3/29/23 Rebecca Paintin 3/29/23 The Timeline Scroll: a prop, a stunt, or a good place to start? Read More Bruce Pierce 2/20/23 Bruce Pierce 2/20/23 How long does it take to write an IND submission? Read More Rebecca Paintin 12/21/22 Rebecca Paintin 12/21/22 Review Documents Like A Pro! Read More Rebecca Paintin 12/14/22 Rebecca Paintin 12/14/22 Drug Development 101: How to Build a Good Review Team, Tip #4 Read More Rebecca Paintin 12/13/22 Rebecca Paintin 12/13/22 Drug Development 101: How to Build a Good Review Team, Tip #3 Read More Rebecca Paintin 12/8/22 Rebecca Paintin 12/8/22 Drug Development 101: How to Build a Good Review Team, Tip #2 Read More Bruce Pierce 12/8/22 Bruce Pierce 12/8/22 Drug Development 101: How to Build a Good Review Team, Tip #1 Read More Widaly Infantino 11/29/22 Widaly Infantino 11/29/22 Tips for Argumentation in Regulatory Writing Read More Widaly Infantino 11/15/22 Widaly Infantino 11/15/22 Reflections on AMWA 2022 Read More Widaly Infantino 11/3/22 Widaly Infantino 11/3/22 If You Build Them, Data Will Come: Making the Most of CRFs Read More Widaly Infantino 9/20/22 Widaly Infantino 9/20/22 Yes, We Do Meaningful Work Read More Widaly Infantino 9/1/22 Widaly Infantino 9/1/22 Update to How We Write About Race in Manuscripts Read More Widaly Infantino 8/30/22 Widaly Infantino 8/30/22 Ensure You Contextualize the Patient Population in Manuscripts Read More Widaly Infantino 8/24/22 Widaly Infantino 8/24/22 What Content Can be Re-Published Read More Widaly Infantino 7/5/22 Widaly Infantino 7/5/22 The Perfect Document is Like a Well Curated Museum Exhibit Read More Widaly Infantino 6/16/22 Widaly Infantino 6/16/22 Introducing Tim Henion: The Secret to the Awesome Sauce Read More Widaly Infantino 6/7/22 Widaly Infantino 6/7/22 Introduction to eCTD in Regulatory Submissions Read More Widaly Infantino 6/2/22 Widaly Infantino 6/2/22 QC Review Read More Widaly Infantino 5/25/22 Widaly Infantino 5/25/22 Medical Writing 101 – Don’t Recreate the Wheel Read More Justin McLaughlin 5/17/22 Justin McLaughlin 5/17/22 Dose-Limiting Toxicities (DLTs) in Phase 1 Clinical Studies – Prepare for Regulatory Success Read More Newer Posts Older Posts
Rebecca Paintin 3/29/23 Rebecca Paintin 3/29/23 The Timeline Scroll: a prop, a stunt, or a good place to start? Read More
Bruce Pierce 2/20/23 Bruce Pierce 2/20/23 How long does it take to write an IND submission? Read More
Rebecca Paintin 12/14/22 Rebecca Paintin 12/14/22 Drug Development 101: How to Build a Good Review Team, Tip #4 Read More
Rebecca Paintin 12/13/22 Rebecca Paintin 12/13/22 Drug Development 101: How to Build a Good Review Team, Tip #3 Read More
Rebecca Paintin 12/8/22 Rebecca Paintin 12/8/22 Drug Development 101: How to Build a Good Review Team, Tip #2 Read More
Bruce Pierce 12/8/22 Bruce Pierce 12/8/22 Drug Development 101: How to Build a Good Review Team, Tip #1 Read More
Widaly Infantino 11/29/22 Widaly Infantino 11/29/22 Tips for Argumentation in Regulatory Writing Read More
Widaly Infantino 11/3/22 Widaly Infantino 11/3/22 If You Build Them, Data Will Come: Making the Most of CRFs Read More
Widaly Infantino 9/1/22 Widaly Infantino 9/1/22 Update to How We Write About Race in Manuscripts Read More
Widaly Infantino 8/30/22 Widaly Infantino 8/30/22 Ensure You Contextualize the Patient Population in Manuscripts Read More
Widaly Infantino 7/5/22 Widaly Infantino 7/5/22 The Perfect Document is Like a Well Curated Museum Exhibit Read More
Widaly Infantino 6/16/22 Widaly Infantino 6/16/22 Introducing Tim Henion: The Secret to the Awesome Sauce Read More
Widaly Infantino 6/7/22 Widaly Infantino 6/7/22 Introduction to eCTD in Regulatory Submissions Read More
Widaly Infantino 5/25/22 Widaly Infantino 5/25/22 Medical Writing 101 – Don’t Recreate the Wheel Read More
Justin McLaughlin 5/17/22 Justin McLaughlin 5/17/22 Dose-Limiting Toxicities (DLTs) in Phase 1 Clinical Studies – Prepare for Regulatory Success Read More